Ani Pharmaceuticals (ANIP) Inventory Average (2013 - 2026)

Ani Pharmaceuticals has disclosed Inventory Average across 14 years of filings, most recently posting $143.3 million for Q2 2026.

• In Q2 2026, Inventory Average rose 3.95% year-over-year to $143.3 million; the TTM figure through Jun 2026 stood at $143.3 million (up 3.95% YoY), while the FY2025 annual figure was $139.9 million, up 12.85% from the prior year.
• Inventory Average came in at $143.3 million for Q2 2026 at Ani Pharmaceuticals, roughly flat from $143.3 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $144.8 million in Q4 2025 to a low of $89.9 million in Q1 2022.
• Average Inventory Average over 5 years is $120.9 million, with a median of $116.1 million recorded in 2024.
• Year-over-year, Inventory Average surged 46.93% in 2022 and climbed 1.66% in 2025.
• Over 5 years, Inventory Average stood at $105.3 million in 2022, then increased by 3.37% to $108.9 million in 2023, then soared by 30.78% to $142.4 million in 2024, then advanced by 1.66% to $144.8 million in 2025, then declined by 1.01% to $143.3 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $143.3 million in Q2 2026, $143.3 million in Q1 2026, and $144.8 million in Q4 2025.